Press Releases

Search Press Releases:

Search Input

• All News
• 2022
• 2021
• 2020
• 2019
• 2018
• 2017
• 2016
• 2015
• 2014
• 2013
• 2012
• 2011
• 2010

Tonix Pharmaceuticals Completes Positive Pre-IND Meeting with FDA for TNX-102 SL (Cyclobenzaprine HCI Sublingual Tablets) as a Clinical Candidate for Agitation in Alzheimer’s Disease

December 12, 2017 • 7:00 AM EST

Tonix Pharmaceuticals to Present at 10th Annual LD Micro Investor Conference

November 30, 2017 • 7:00 AM EST

Tonix Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Programs Update

November 7, 2017 • 7:00 AM EST

Tonix Pharmaceuticals to Present at 23rd Annual BIO-Europe International Partnering Conference

November 1, 2017 • 7:00 AM EDT

Tonix Pharmaceuticals Reports Outcomes from U.S. FDA Breakthrough Therapy CMC Guidance Meeting of Tonmya® (Cyclobenzaprine HCI Sublingual Tablets) for PTSD

October 17, 2017 • 7:00 AM EDT

Tonix Pharmaceuticals to Present at the Dawson James Securities 3rd Annual Small Cap Growth Conference

October 12, 2017 • 7:00 AM EDT

Tonix Pharmaceuticals Presented at the 2nd Annual Cohen Veterans Care Summit in Washington, D.C.

September 29, 2017 • 7:00 AM EDT

Tonix Pharmaceuticals Receives European Patent for the Active Ingredient in Tonmya® (Cyclobenzaprine HCl Sublingual Tablets)

September 14, 2017 • 4:05 PM EDT

Tonix Pharmaceuticals Elects Margaret Smith Bell to the Board of Directors

September 14, 2017 • 7:00 AM EDT

Tonix Pharmaceuticals to Present at the Rodman & Renshaw 19th Annual Global Investment Conference

September 6, 2017 • 7:00 AM EDT

• 1
• 2
• 3
• 4
• 5
• Next »